About Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in developing products in cardiovascular and autoimmune disease that have the potential to restore the health of people with chronic illnesses. Its product pipeline includes CLBS12, CLBS14, and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.69$ per share.

The book value per share is 4.50$

Caladrius Biosciences, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -21M - -15M -1.69 - - 10M 4.50 -21M - -21M